Detailed Instructions: In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.
See one example below:
Problem: SECTION 1. LIABILITY OF BUSINESS ENTITIES PROVIDING USE OF FACILITIES
TO NONPROFIT ORGANIZATIONS.

(a) Definitions.--In this section:
(1) Business entity.--The term ''business entity'' means a
firm, corporation, association, partnership, consortium, joint
venture, or other form of enterprise.
(2) Facility.--The term ''facility'' means any real
property, including any building, improvement, or appurtenance.
(3) Gross negligence.--The term ''gross negligence'' means
voluntary and conscious conduct by a person with knowledge (at
the time of the conduct) that the conduct is likely to be
harmful to the health or well-being of another person.
(4) Intentional misconduct.--The term ''intentional
misconduct'' means conduct by a person with knowledge (at the
time of the conduct) that the conduct is harmful to the health
or well-being of another person.
(5) Nonprofit organization.--The term ''nonprofit
organization'' means--
(A) any organization described in section 501(c)(3)
of the Internal Revenue Code of 1986 and exempt from
tax under section 501(a) of such Code; or
(B) any not-for-profit organization organized and
conducted for public benefit and operated primarily for
charitable, civic, educational, religious, welfare, or
health purposes.
(6) State.--The term ''State'' means each of the several
States, the District of Columbia, the Commonwealth of Puerto
Rico, the Virgin Islands, Guam, American Samoa, the Northern
Mariana Islands, any other territory or possession of the
United States, or any political subdivision of any such State,
territory, or possession.
(b) Limitation on Liability.--
(1) In general.--Subject to subsection (c), a business
entity shall not be subject to civil liability relating to any
injury or death occurring at a facility of the business entity
in connection with a use of such facility by a nonprofit
organization if--
(A) the use occurs outside of the scope of business
of the business entity;
(B) such injury or death occurs during a period
that such facility is used by the nonprofit
organization; and
(C) the business entity authorized the use of such
facility by the nonprofit organization.
(2) Application.--This subsection shall apply--
(A) with respect to civil liability under Federal
and State law; and
(B) regardless of whether a nonprofit organization
pays for the use of a facility.
(c) Exception for Liability.--Subsection (b) shall not apply to an
injury or death that results from an act or omission of a business
entity that constitutes gross negligence or intentional misconduct,
including any misconduct that--
(1) constitutes a crime of violence (as that term is
defined in section 16 of title 18, United States Code) or act
of international terrorism (as that term is defined in section
2331 of title 18) for which the defendant has been convicted in
any court;
(2) constitutes a hate crime (as that term is used in the
Hate Crime Statistics Act (28 U.S.C. 534 note));
(3) involves a sexual offense, as defined by applicable
State law, for which the defendant has been convicted in any
court; or
(4) involves misconduct for which the defendant has been
found to have violated a Federal or State civil rights law.
(d) Superseding Provision.--
(1) In general.--Subject to paragraph (2) and subsection
(e), this Act preempts the laws of any State to the extent that
such laws are inconsistent with this Act, except that this Act
shall not preempt any State law that provides additional
protection from liability for a business entity for an injury
or death with respect to which conditions under subparagraphs
(A) through (C) of subsection (b)(1) apply.
(2) Limitation.--Nothing in this Act shall be construed to
supersede any Federal or State health or safety law.
(e) Election of State Regarding Nonapplicability.--This Act shall
not apply to any civil action in a State court against a business
entity in which all parties are citizens of the State if such State
enacts a statute--
(1) citing the authority of this subsection;
(2) declaring the election of such State that this Act
shall not apply to such civil action in the State; and
(3) containing no other provision.
Solution: Shields a business entity from civil liability relating to any injury or death occurring at a facility of that entity in connection with a use of such facility by a nonprofit organization if: (1) the use occurs outside the scope of business of the business entity; (2) such injury or death occurs during a period that such facility is used by such organization; and (3) the business entity authorized the use of such facility by the organization.
Makes this Act inapplicable to an injury or death that results from an act or omission of a business entity that constitutes gross negligence or intentional misconduct, including misconduct that: (1) constitutes a hate crime or a crime of violence or act of international terrorism for which the defendant has been convicted in any court; or (2) involves a sexual offense for which the defendant has been convicted in any court or misconduct for which the defendant has been found to have violated a Federal or State civil rights law.
Preempts State laws to the extent that such laws are inconsistent with this Act, except State law that provides additional protection from liability. Specifies that this Act shall not be construed to supersede any Federal or State health or safety law.
Makes this Act inapplicable to any civil action in a State court against a business entity in which all parties are citizens of the State if such State, citing this Act's authority and containing no other provision, enacts a statute declaring the State's election that this Act shall not apply to such action in the State.
Explanation: This Bill focuses on shielding business entities from civil liability relating to an injury or death depending on the conditions of injury, hence the generated summary is correct.

Problem: SECTION 1. SHORT TITLE; TABLE OF CONTENTS.
(a) Short Title.--This Act may be cited as the ''Comprehensive
Tuberculosis Elimination Act of 2008''.
(b) Table of Contents.--The table of contents for this Act is as
follows:

Sec. 1. Short title; table of contents.

TITLE I--DEPARTMENT OF HEALTH AND HUMAN SERVICES IN COORDINATION WITH
THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND OTHER APPROPRIATE
AGENCIES

Subtitle A--National Strategy for Combating and Eliminating Tuberculosis

Sec. 101. National strategy.

Subtitle B--Interagency Collaboration

Sec. 111. Advisory Council for Elimination of Tuberculosis and the
Federal Tuberculosis Task Force .

Subtitle C--Evaluation of Public Health Authorities

Sec. 121. Evaluation of public health authorities.

Subtitle D--Authorization of Appropriations

Sec. 131. Authorizations of appropriations.

TITLE II--NATIONAL INSTITUTES OF HEALTH

Sec. 201. Research and development concerning tuberculosis.

TITLE I--DEPARTMENT OF HEALTH AND HUMAN SERVICES IN COORDINATION WITH
THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND OTHER APPROPRIATE
AGENCIES
Subtitle A--National Strategy for Combating and Eliminating
Tuberculosis

SEC. 101. NATIONAL STRATEGY.
Section 317E of the Public Health Service Act (42 U.S.C. 247b-6) is
amended--
(1) by striking the heading for the section and inserting the
following: ''national strategy for combating and eliminating
tuberculosis'';
(2) by amending subsection (b) to read as follows:
''(b) Research and Development; Demonstration Projects; Education
and Training.--With respect to the prevention, treatment, control, and
elimination of tuberculosis, the Secretary may, directly or through
grants to public or nonprofit private entities, carry out the
following:
''(1) Research, with priority given to research and development
concerning latent tuberculosis infection, strains of tuberculosis
resistant to drugs, and research concerning cases of tuberculosis
that affect certain populations at risk for tuberculosis.
''(2) Research and development and related activities to
develop new tools for the elimination of tuberculosis, including
drugs, diagnostics, vaccines, and public health interventions, such
as directly observed therapy and non-pharmaceutical intervention,
and methods to enhance detection and response to outbreaks of
tuberculosis, including multidrug resistant tuberculosis. The
Secretary is encouraged to give priority to programmatically
relevant research so that new tools can be utilized in public
health practice.
''(3) Demonstration projects for--
''(A) the development of regional capabilities to prevent,
control, and eliminate tuberculosis and prevent multidrug
resistant and extensively drug resistant strains of
tuberculosis;
''(B) the intensification of efforts to reduce health
disparities in the incidence of tuberculosis;
''(C) the intensification of efforts to control
tuberculosis along the United States-Mexico border and among
United States-Mexico binational populations, including through
expansion of the scope and number of programs that--
''(i) detect and treat binational cases of
tuberculosis; and
''(ii) treat high-risk cases of tuberculosis referred
from Mexican health departments;
''(D) the intensification of efforts to prevent, detect,
and treat tuberculosis among foreign-born persons who are in
the United States;
''(E) the intensification of efforts to prevent, detect,
and treat tuberculosis among populations and settings
documented as having a high risk for tuberculosis; and
''(F) tuberculosis detection, control, and prevention.
''(4) Public information and education activities.
''(5) Education, training, clinical skills improvement
activities, and workplace exposure prevention for health
professionals, including allied health personnel and emergency
response employees.
''(6) Support of Centers to carry out activities under
paragraphs (1) through (4).
''(7) Collaboration with international organizations and
foreign countries in carrying out such activities.
''(8) Develop, enhance, and expand information technologies
that support tuberculosis control including surveillance and
database management systems with cross-jurisdictional capabilities,
which shall conform to the standards and implementation
specifications for such information technologies as recommended by
the Secretary.''; and
(3) in subsection (d), by adding at the end the following:
''(3) Determination of amount of nonfederal contributions.--
''(A) Priority.--In awarding grants under subsection (a) or
(b), the Secretary shall give highest priority to an applicant
that provides assurances that the applicant will contribute
non-Federal funds to carry out activities under this section,
which may be provided directly or through donations from public
or private entities and may be in cash or in kind, including
equipment or services.
''(B) Federal amounts not to be included as
contributions.--Amounts provided by the Federal Government, or
services assisted or subsidized to any significant extent by
the Federal Government, may not be included in determining the
amount of non-Federal contributions as described in
subparagraph (A).''.

Subtitle B--Interagency Collaboration

SEC. 111. ADVISORY COUNCIL FOR ELIMINATION OF TUBERCULOSIS AND THE
FEDERAL TUBERCULOSIS TASK FORCE.
(a) In General.--Section 317E(f) of the Public Health Service Act
(42 U.S.C. 247b-6(f)) is amended--
(1) by redesignating paragraph (5) as paragraph (6); and
(2) by striking paragraphs (2) through (4), and inserting the
following:
''(2) Duties.--The Council shall provide advice and
recommendations regarding the elimination of tuberculosis to the
Secretary. In addition, the Council shall, with respect to
eliminating such disease, provide to the Secretary and other
appropriate Federal officials advice on--
''(A) coordinating the activities of the Department of
Health and Human Services and other Federal agencies that
relate to the disease, including activities under subsection
(b);
''(B) responding rapidly and effectively to emerging issues
in tuberculosis; and
''(C) efficiently utilizing the Federal resources involved.
''(3) Comprehensive plan.--
''(A) In general.--In carrying out paragraph (2), the
Council shall make or update recommendations on the
development, revision, and implementation of a comprehensive
plan to eliminate tuberculosis in the United States.
''(B) Consultation.--In carrying out subparagraph (A), the
Council may consult with appropriate public and private
entities, which may, subject to the direction or discretion of
the Secretary, include--
''(i) individuals who are scientists, physicians,
laboratorians, and other health professionals, who are not
officers or employees of the Federal Government and who
represent the disciplines relevant to tuberculosis
elimination;
''(ii) members of public-private partnerships or
private entities established to address the elimination of
tuberculosis;
''(iii) members of national and international
nongovernmental organizations whose purpose is to eliminate
tuberculosis;
''(iv) members from the general public who are
knowledgeable with respect to tuberculosis elimination
including individuals who have or have had tuberculosis;
and
''(v) scientists, physicians, laboratorians, and other
health professionals who reside in a foreign country with a
substantial incidence or prevalence of tuberculosis, and
who represent the specialties and disciplines relevant to
the research under consideration.
''(C) Certain components of plan.--In carrying out
subparagraph (A), the Council shall, subject to the direction
or discretion of the Secretary--
''(i) consider recommendations for the involvement of
the United States in continuing global and cross-border
tuberculosis control activities in countries where a high
incidence of tuberculosis directly affects the United
States; and
''(ii) review the extent to which progress has been
made toward eliminating tuberculosis.
''(4) Biennial report.--
''(A) In general.--The Council shall submit a biennial
report to the Secretary, as determined necessary by the
Secretary, on the activities carried under this section. Each
such report shall include the opinion of the Council on the
extent to which its recommendations regarding the elimination
of tuberculosis have been implemented, including with respect
to--
''(i) activities under subsection (b); and
''(ii) the national plan referred to in paragraph (3).
''(B) Public.--The Secretary shall make a report submitted
under subparagraph (A) public.
''(5) Composition.--The Council shall be composed of--
''(A) ex officio representatives from the Centers for
Disease Control and Prevention, the National Institutes of
Health, the United States Agency for International Development,
the Agency for Healthcare Research and Quality, the Health
Resources and Services Administration, the United States-Mexico
Border Health Commission, and other Federal departments and
agencies that carry out significant activities related to
tuberculosis;
''(B) State and local tuberculosis control and public
health officials;
''(C) individuals who are scientists, physicians,
laboratorians, and other health professionals who represent
disciplines relevant to tuberculosis elimination; and
''(D) members of national and international nongovernmental
organizations established to address the elimination of
tuberculosis.''.
(b) Rule of Construction Regarding Current Membership.--With
respect to the advisory council under section 317E(f) of the Public
Health Service Act, the amendments made by subsection (a) may not be
construed as terminating the membership on such council of any
individual serving as such a member as of the day before the date of
the enactment of this Act.
(c) Federal Tuberculosis Task Force.--Section 317E of the Public
Health Service Act (42 U.S.C. 247b-6) is amended--
(1) by redesignating subsection (g) as subsection (h); and
(2) by inserting after subsection (f) the following subsection:
''(g) Federal Tuberculosis Task Force.--
''(1) Duties.--The Federal Tuberculosis Task Force (in this
subsection referred to as the 'Task Force') shall provide to the
Secretary and other appropriate Federal officials advice on
research into new tools under subsection (b)(2), including advice
regarding the efficient utilization of the Federal resources
involved.
''(2) Comprehensive plan for new tools development.--In
carrying out paragraph (1), the Task Force shall make
recommendations on the development of a comprehensive plan for the
creation of new tools for the elimination of tuberculosis,
including drugs, diagnostics, and vaccines.
''(3) Consultation.--In developing the comprehensive plan under
paragraph (1), the Task Force shall consult with external parties
including representatives from groups such as--
''(A) scientists, physicians, laboratorians, and other
health professionals who represent the specialties and
disciplines relevant to the research under consideration;
''(B) members from public-private partnerships, private
entities, or foundations (or both) engaged in activities
relevant to research under consideration;
''(C) members of national and international nongovernmental
organizations established to address tuberculosis elimination;
''(D) members from the general public who are knowledgeable
with respect to tuberculosis including individuals who have or
have had tuberculosis; and
''(E) scientists, physicians, laboratorians, and other
health professionals who reside in a foreign country with a
substantial incidence or prevalence of tuberculosis, and who
represent the specialties and disciplines relevant to the
research under consideration.''.

Subtitle C--Evaluation of Public Health Authorities

SEC. 121. EVALUATION OF PUBLIC HEALTH AUTHORITIES.
(a) In General.--Not later than 180 days after the date of
enactment of the Comprehensive Tuberculosis Elimination Act of 2008,
the Secretary of Health and Human Services shall prepare and submit to
the appropriate committees of Congress a report that evaluates and
provides recommendations on changes needed to Federal and State public
health authorities to address current disease containment challenges
such as isolation and quarantine.
(b) Contents of Evaluation.--The report described in subsection (a)
shall include--
(1) an evaluation of the effectiveness of current policies to
detain patients with active tuberculosis;
(2) an evaluation of whether Federal laws should be
strengthened to expressly address the movement of individuals with
active tuberculosis; and
(3) specific legislative recommendations for changes to Federal
laws, if any.
(c) Update of Quarantine Regulations.--Not later than 240 days
after the date of enactment of this Act, the Secretary of Health and
Human Services shall promulgate regulations to update the current
interstate and foreign quarantine regulations found in parts 70 and 71
of title 42, Code of Federal Regulations.

Subtitle D--Authorization of Appropriations

SEC. 131. AUTHORIZATIONS OF APPROPRIATIONS.
Section 317E of the Public Health Service Act, as amended by
section 111(c) of this Act, is amended by striking subsection (h) and
inserting the following:
''(h) Authorization of Appropriations.--
''(1) General program.--
''(A) In general.--For the purpose of carrying out this
section, there are authorized to be appropriated $200,000,000
for fiscal year 2009, $210,000,000 for fiscal year 2010,
$220,500,000 for fiscal year 2011, $231,525,000 for fiscal year
2012, and $243,101,250 for fiscal year 2013.
''(B) Reservation for emergency grants.--Of the amounts
appropriated under subparagraph (A) for a fiscal year, the
Secretary may reserve not more than 25 percent for emergency
grants under subsection (a) for any geographic area, State,
political subdivision of a State, or other public entity in
which there is, relative to other areas, a substantial number
of cases of tuberculosis, multidrug resistant tuberculosis, or
extensively drug resistant tuberculosis or a substantial rate
of increase in such cases.
''(C) Priority.--In allocating amounts appropriated under
subparagraph (A), the Secretary shall give priority to
allocating such amounts for grants under subsection (a).
''(D) Allocation of funds.--
''(i) Requirement of formula.--Of the amounts
appropriated under subparagraph (A), not reserved under
subparagraph (B), and allocated by the Secretary for grants
under subsection (a), the Secretary shall distribute a
portion of such amounts to grantees under subsection (a) on
the basis of a formula.
''(ii) Relevant factors.--The formula developed by the
Secretary under clause (i) shall take into account the
level of tuberculosis morbidity and case complexity in the
respective geographic area and may consider other factors
relevant to tuberculosis in such area.
''(iii) No change to formula required.--This
subparagraph does not require the Secretary to modify the
formula that was used by the Secretary to distribute funds
to grantees under subsection (a) for fiscal year 2009.
''(2) Limitation.--The authorization of appropriations
established in paragraph (1) for a fiscal year is effective only if
the amount appropriated under such paragraph for such year equals
or exceeds the amount appropriated to carry out this section for
fiscal year 2009.''.

TITLE II--NATIONAL INSTITUTES OF HEALTH

SEC. 201. RESEARCH AND DEVELOPMENT CONCERNING TUBERCULOSIS.
Subpart 2 of part C of title IV of the Public Health Service Act
(42 U.S.C. 285b et seq.) is amended by inserting after section 424B the
following section:
''SEC. 424C. TUBERCULOSIS.
''(a) In General.--The Director of the National Institutes of
Health may expand, intensify, and coordinate research and development
and related activities of the Institutes with respect to tuberculosis
including activities toward the goal of eliminating such disease.
''(b) Certain Activities.--Activities under subsection (a) may
include--
''(1) enhancing basic and clinical research on tuberculosis,
including drug resistant tuberculosis;
''(2) expanding research on the relationship between such
disease and the human immunodeficiency virus; and
''(3) developing new tools for the elimination of tuberculosis,
including public health interventions and methods to enhance
detection and response to outbreaks of tuberculosis, including
multidrug resistant tuberculosis.''.

Speaker of the House of Representatives.

Vice President of the United States and
President of the Senate.
Solution:
Comprehensive Tuberculosis Elimination Act of 2008 - Title I: Department of Health and Human Services in Coordination with the Centers for Disease Control and Prevention and Other Appropriate Agencies - Subtitle A: National Strategy for Combating and Eliminating Tuberculosis - (Sec. 101) Amends the Public Health Service Act to revise the grant program through which the Secretary of Health and Human Services is authorized to carry out programs with respect to the prevention, treatment, control, and elimination of tuberculosis.

Includes research on latent tuberculosis infection within such program.

Includes within such program research and development and related activities to develop new tools for the elimination of tuberculosis and new methods to enhance detection and response to tuberculosis outbreaks. Encourages the Secretary to give priority to programmatically relevant research so that new tools can be utilized in public health practice.

Includes among demonstration projects the Secretary may carry out as part of such program projects for the development of regional capabilities to prevent, control, and eliminate tuberculosis and prevent multidrug resistant and extensively drug resistant strains of tuberculosis and projects for the intensification of efforts to: (1) reduce health disparities in the incidence of tuberculosis; (2) control tuberculosis along the U.S.-Mexico border; (3) prevent, detect, and treat tuberculosis among foreign-born persons who are in the United States; and (4) prevent, detect, and treat tuberculosis in high-risk populations and settings.

Allows the Secretary, as part of such program, to develop, enhance, and expand information technologies that support tuberculosis control, including surveillance and database management systems with cross-jurisdictional capabilities.

Requires the Secretary, in awarding grants for such tuberculosis programs, to give highest priority to applicants that will contribute nonfederal funds to carry out such activities.

Subtitle B: Interagency Collaboration - (Sec. 111) Expands the duties for the Advisory Council for the Elimination of Tuberculosis to include providing to the Secretary and other appropriate federal officials advice on: (1) coordinating the activities of the Department of Health and Human Services (HHS) and other federal agencies; (2) responding rapidly and effectively to emerging issues in tuberculosis; and (3) efficiently utilizing the federal resources involved. Requires the Council to make or update recommendations on the comprehensive plan to eliminate tuberculosis in the United States. Sets forth reporting requirements for the Council.

Requires the Federal Tuberculosis Task Force to: (1) provide to the Secretary and other appropriate federal officials advice on research into new tools; and (2) make recommendations on the development of a comprehensive plan for the creation of new tools for the elimination of tuberculosis.

Subtitle C: Evaluation of Public Health Authorities - (Sec. 121) Requires the Secretary to: (1) report to the appropriate congressional committees on changes needed to federal and state public health authorities to address current disease containment challenges; and (2) promulgate regulations to update current interstate and foreign quarantine regulations.

Subtitle D: Authorization of Appropriations - (Sec. 131) Authorizes appropriations for FY2009-FY2013. Requires the Secretary to allocate a portion of grant funds on the basis of a formula that takes into account the level of tuberculosis morbidity and case complexity in the respective geographic area.

Title II: National Institutes of Health - (Sec. 201) Allows the Director of the National Institutes of Health (NIH) to expand, intensify, and coordinate research and development and related NIH activities with respect to tuberculosis. Authorizes such activities to include: (1) enhancing basic and clinical research on tuberculosis, including drug resistant tuberculosis; (2) expanding research on the relationship between tuberculosis and the human immunodeficiency virus; and (3) developing new tools for the elimination of tuberculosis, including public health interventions and methods to enhance detection and response to outbreaks of tuberculosis.